1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.
Saved in:
| Title: | 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Johnson TS; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.; Indiana Biosciences Research Institute, Indianapolis, IN, USA.; Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, USA.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA., Sudha P; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Liu E; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Becker N; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Robertson S; Indiana Biosciences Research Institute, Indianapolis, IN, USA., Blaney P; Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA., Morgan G; Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA., Chopra VS; Genentech Inc., South San Francisco, CA, USA., Dos Santos C; Genentech Inc., South San Francisco, CA, USA., Nixon M; Roche Inc., Indianapolis, IN, USA., Huang K; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.; Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, USA.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA., Suvannasankha A; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.; Roudebush VAMC, Indianapolis, IN, USA., Zaid MA; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Abonour R; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA., Walker BA; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA. bw75@iu.edu.; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA. bw75@iu.edu. |
| Source: | Nature communications [Nat Commun] 2024 May 16; Vol. 15 (1), pp. 4144. Date of Electronic Publication: 2024 May 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38755140 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johnson+TS%22">Johnson TS</searchLink>; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.; Indiana Biosciences Research Institute, Indianapolis, IN, USA.; Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, USA.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sudha+P%22">Sudha P</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Liu+E%22">Liu E</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Becker+N%22">Becker N</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Robertson+S%22">Robertson S</searchLink>; Indiana Biosciences Research Institute, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Blaney+P%22">Blaney P</searchLink>; Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+G%22">Morgan G</searchLink>; Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chopra+VS%22">Chopra VS</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dos+Santos+C%22">Dos Santos C</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nixon+M%22">Nixon M</searchLink>; Roche Inc., Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Huang+K%22">Huang K</searchLink>; Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.; Melvin and Bren Simon Comprehensive Cancer Center, Experimental and Developmental Therapeutics, School of Medicine, Indiana University, Indianapolis, IN, USA.; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Suvannasankha+A%22">Suvannasankha A</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.; Roudebush VAMC, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Zaid+MA%22">Zaid MA</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Abonour+R%22">Abonour R</searchLink>; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Walker+BA%22">Walker BA</searchLink>; Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University, Indianapolis, IN, USA. bw75@iu.edu.; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA. bw75@iu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 May 16; Vol. 15 (1), pp. 4144. <i>Date of Electronic Publication: </i>2024 May 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38755140 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-48327-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4144 Titles: – TitleFull: 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johnson TS – PersonEntity: Name: NameFull: Sudha P – PersonEntity: Name: NameFull: Liu E – PersonEntity: Name: NameFull: Becker N – PersonEntity: Name: NameFull: Robertson S – PersonEntity: Name: NameFull: Blaney P – PersonEntity: Name: NameFull: Morgan G – PersonEntity: Name: NameFull: Chopra VS – PersonEntity: Name: NameFull: Dos Santos C – PersonEntity: Name: NameFull: Nixon M – PersonEntity: Name: NameFull: Huang K – PersonEntity: Name: NameFull: Suvannasankha A – PersonEntity: Name: NameFull: Zaid MA – PersonEntity: Name: NameFull: Abonour R – PersonEntity: Name: NameFull: Walker BA IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 05 Text: 2024 May 16 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |